Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Gunnar Sæter

98 publications found

Original articles

Kehrloesser S, Oberst S, Westerhuis W, Wendler A, Wind A, Blaauwgeers H, Burrion JB, Nagy P, Saeter G, Gustafsson E, De Paoli P, Lovey J, Lombardo C, Philip T, de Valeriola D, Docter M, Boomsma F, Saghatchian M, Svoboda M, Philip I, Monetti F, Hummel H, McVie G, Otter R, van Harten W (2021)
Analysing the attributes of Comprehensive Cancer Centres and Cancer Centres across Europe to identify key hallmarks
Mol Oncol, 15 (5), 1277-1288
DOI 10.1002/1878-0261.12950, PubMed 33734563

Aapro M, Astier A, Audisio R, Banks I, Bedossa P, Brain E, Cameron D, Casali P, Chiti A, De Mattos-Arruda L, Kelly D, Lacombe D, Nilsson PJ, Piccart M, Poortmans P, Riklund K, Saeter G, Schrappe M, Soffietti R, Travado L, van Poppel H, Wait S, Naredi P (2017)
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
Eur J Cancer, 82, 193-202
DOI 10.1016/j.ejca.2017.04.014, PubMed 28692951

Stark D, Bielack S, Brugieres L, Dirksen U, Duarte X, Dunn S, Erdelyi DJ, Grew T, Hjorth L, Jazbec J, Kabickova E, Konsoulova A, Kowalczyk JR, Lassaletta A, Laurence V, Lewis I, Monrabal A, Morgan S, Mountzios G, Olsen PR, Renard M, Saeter G, van der Graaf WT, Ferrari A (2015)
Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project
Eur J Cancer Care (Engl), 25 (3), 419-27
DOI 10.1111/ecc.12365, PubMed 26239724

Ohnstad HO, Bruland OS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, Jørgensen LH, Hall KS (2014)
Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?
Acta Oncol, 53 (9), 1180-7
DOI 10.3109/0284186X.2014.899433, PubMed 24697744

Boye K, Del Prever AB, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KS (2013)
High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study
Pediatr Blood Cancer, 61 (5), 840-5
DOI 10.1002/pbc.24868, PubMed 24254749

Namløs HM, Kresse SH, Müller CR, Henriksen J, Holdhus R, Sæter G, Bruland OS, Bjerkehagen B, Steen VM, Myklebost O (2012)
Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern
Sarcoma, 2012, 639038
DOI 10.1155/2012/639038, PubMed 22518090

Jenum PA, Flesland Ø, Blystad H, Vik IS, Hervig T, Maeland A, Saeter G (2010)
[Syphilis and blood transfusion]
Tidsskr Nor Laegeforen, 130 (8), 839-41
DOI 10.4045/tidsskr.08.0188, PubMed 20418930

Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, Småstuen MC, Fosså SD, Saeter G (2008)
Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
Acta Oncol, 47 (8), 1475-82
DOI 10.1080/02841860802047387, PubMed 18607853

Müller CR, Paulsen EB, Noordhuis P, Pedeutour F, Saeter G, Myklebost O (2007)
Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A
Int J Cancer, 121 (1), 199-205
DOI 10.1002/ijc.22643, PubMed 17354236

ESMO Guidelines Working Group, Saeter G (2007)
Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
Ann Oncol, 18 Suppl 2, ii77-8
DOI 10.1093/annonc/mdm047, PubMed 17491058

ESMO Guidelines Working Group, Saeter G (2007)
Ewing's sarcoma of bone: ESMO clinical recommendations for diagnosis, treatment and follow-up
Ann Oncol, 18 Suppl 2, ii79-80
DOI 10.1093/annonc/mdm048, PubMed 17491059

Aksnes LH, Hall KS, Folleraas G, Stenwig AE, Bjerkehagen B, Taksdal I, Winderen M, Bruland OS, Saeter G (2006)
Management of high-grade bone sarcomas over two decades: the Norwegian Radium Hospital experience
Acta Oncol, 45 (1), 38-46
DOI 10.1080/02841860500466624, PubMed 16464794

Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups (2005)
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups
J Clin Oncol, 23 (34), 8845-52
DOI 10.1200/JCO.2004.00.5785, PubMed 16246977

Bruland OS, Høifødt H, Saeter G, Smeland S, Fodstad O (2005)
Hematogenous micrometastases in osteosarcoma patients
Clin Cancer Res, 11 (13), 4666-73
DOI 10.1158/1078-0432.CCR-05-0165, PubMed 16000559

Saeter G, Oliveira J, Bergh J, ESMO Guidelines Task Force (2005)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Ewing's sarcoma of bone
Ann Oncol, 16 Suppl 1, i73-4
DOI 10.1093/annonc/mdi811, PubMed 15888765

Müller CR, Smeland S, Bauer HC, Saeter G, Strander H (2005)
Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series
Acta Oncol, 44 (5), 475-80
DOI 10.1080/02841860510029978, PubMed 16118081

Saeter G, Kloke O, Jelic S, ESMO Guidelines Task Force (2005)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of osteosarcoma
Ann Oncol, 16 Suppl 1, i71-2
DOI 10.1093/annonc/mdi822, PubMed 15888764

Tropé C, Kaern J, Saeter G, Gore M (2003)
[Paclitaxel should be included in standard therapy of ovarian carcinoma]
Tidsskr Nor Laegeforen, 123 (21), 3083-4
PubMed 14618184

Saeter G, European Society for Medical Oncology (2003)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Ewing's sarcoma of bone
Ann Oncol, 14 (8), 1167-8
DOI 10.1093/annonc/mdg335, PubMed 12881370

Saeter G, European Society for Medical Oncology (2003)
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of osteosarcoma
Ann Oncol, 14 (8), 1165-6
DOI 10.1093/annonc/mdg336, PubMed 12881369

Micci F, Walter CU, Teixeira MR, Panagopoulos I, Bjerkehagen B, Saeter G, Heim S (2003)
Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17)
Cancer Genet Cytogenet, 144 (2), 119-24
DOI 10.1016/s0165-4608(03)00025-6, PubMed 12850374

Smeland S, Müller C, Alvegard TA, Wiklund T, Wiebe T, Björk O, Stenwig AE, Willén H, Holmström T, Follerås G, Brosjö O, Kivioja A, Jonsson K, Monge O, Saeter G (2003)
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
Eur J Cancer, 39 (4), 488-94
DOI 10.1016/s0959-8049(02)00747-5, PubMed 12751380

Grimer RJ, Cannon SR, Taminiau AM, Bielack S, Kempf-Bielack B, Windhager R, Dominkus M, Saeter G, Bauer H, Meller I, Szendroi M, Folleras G, San-Julian M, van der Eijken J (2003)
Osteosarcoma over the age of forty
Eur J Cancer, 39 (2), 157-63
DOI 10.1016/s0959-8049(02)00478-1, PubMed 12509946

Saeter G, Hall KS, Bruland ØS, Solheim ØP, Høie J, Follerås G, Helgerud P, Stenwig AE, Bjerkehagen B, Talle K, Taksdal I, Winderen M (2002)
[Bone and soft tissue sarcomas treated at the Norwegian Radium Hospital 1980-99]
Tidsskr Nor Laegeforen, 122 (21), 2089-94
PubMed 12555642

Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA, Saeter G, Donati D, Manfrini M, Lari S, Briccoli A, Forni C, Italian Sarcoma Group/Scandinavian Sarcoma Group (2002)
High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study
J Chemother, 14 (2), 198-206
DOI 10.1179/joc.2002.14.2.198, PubMed 12017378

Picci P, Vanel D, Briccoli A, Talle K, Haakenaasen U, Malaguti C, Monti C, Ferrari C, Bacci G, Saeter G, Alvegard TA (2001)
Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation
Ann Oncol, 12 (11), 1601-4
DOI 10.1023/a:1013103511633, PubMed 11822761

Bauer HC, Trovik CS, Alvegård TA, Berlin O, Erlanson M, Gustafson P, Klepp R, Möller TR, Rydholm A, Saeter G, Wahlström O, Wiklund T (2001)
Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register
Acta Orthop Scand, 72 (2), 150-9
DOI 10.1080/000164701317323408, PubMed 11372946

Trovik CS, Bauer HC, Berlin O, Tukiainen E, Erlanson M, Gustafson P, Klepp R, Saeter G, Wahlström O (2001)
Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register
Acta Orthop Scand, 72 (2), 160-6
DOI 10.1080/000164701317323417, PubMed 11372947

Forus A, Larramendy ML, Meza-Zepeda LA, Bjerkehagen B, Godager LH, Dahlberg AB, Saeter G, Knuutila S, Myklebost O (2001)
Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases
Cancer Genet Cytogenet, 125 (2), 100-11
DOI 10.1016/s0165-4608(00)00369-1, PubMed 11369052

Lothe RA, Smith-Sørensen B, Hektoen M, Stenwig AE, Mandahl N, Saeter G, Mertens F (2001)
Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors
Genes Chromosomes Cancer, 30 (2), 202-6
DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1079>3.0.CO;2-5, PubMed 11135438

Trovik CS, Gustafson P, Bauer HC, Saeter G, Klepp R, Berlin O, Erlanson M, Wahlström O, Raabe N (2000)
Consequences of local recurrence of soft tissue sarcoma: 205 patients from the Scandinavian Sarcoma Group Register
Acta Orthop Scand, 71 (5), 488-95
DOI 10.1080/000164700317381199, PubMed 11186407

Elomaa I, Blomqvist CP, Saeter G, Akerman M, Stenwig E, Wiebe T, Björk O, Alvegård TA (2000)
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol
Eur J Cancer, 36 (7), 875-80
DOI 10.1016/s0959-8049(00)00028-9, PubMed 10785592

Trovik CS, Bauer HC, Alvegård TA, Anderson H, Blomqvist C, Berlin O, Gustafson P, Saeter G, Wallöe A (2000)
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register
Eur J Cancer, 36 (6), 710-6
DOI 10.1016/s0959-8049(99)00287-7, PubMed 10762742

Bacci G, Briccoli A, Ferrari S, Saeter G, Donati D, Longhi A, Manfrini M, Bertoni F, Rimondini S, Monti C, Forni C (2000)
Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide
Oncol Rep, 7 (2), 339-46
DOI 10.3892/or.7.2.339, PubMed 10671683

Panagopoulos I, Mencinger M, Dietrich CU, Bjerkehagen B, Saeter G, Mertens F, Mandahl N, Heim S (1999)
Fusion of the RBP56 and CHN genes in extraskeletal myxoid chondrosarcomas with translocation t(9;17)(q22;q11)
Oncogene, 18 (52), 7594-8
DOI 10.1038/sj.onc.1203155, PubMed 10602519

Skytting BT, Bauer HC, Perfekt R, Huuhtanen R, Alvegård TA, Berlin O, Gustafson P, Klepp R, Löfvenberg R, Saeter G, Trovik CS, Wahlström O (1999)
Clinical course in synovial sarcoma: a Scandinavian sarcoma group study of 104 patients
Acta Orthop Scand, 70 (6), 536-42
DOI 10.3109/17453679908997839, PubMed 10665716

Bjerkehagen B, Dietrich C, Reed W, Micci F, Saeter G, Berner A, Nesland JM, Heim S (1999)
Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11)
Virchows Arch, 435 (5), 524-30
DOI 10.1007/s004280050437, PubMed 10592057

Berner JM, Sørlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, Brøgger A, Myklebost O, Lothe RA (1999)
Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway
Genes Chromosomes Cancer, 26 (2), 151-60
DOI 10.1002/(SICI)1098-2264(199910)26:2<151::AID-GCC7>3.0.CO;2-A, PubMed 10469453

Alvegård TA, Bauer H, Blomqvist C, Möller T, Rydholm A, Saeter G (1999)
The Scandinavian Sarcoma Group. Background, organization and the Central Register--the first 20 years
Acta Orthop Scand Suppl, 285, 3-7
PubMed 10429614

Fernberg JO, Wiklund T, Monge O, Hall KS, Saeter G, Alvegård TA, Strander H (1999)
Chemotherapy in soft tissue sarcoma. The Scandinavian Sarcoma Group experience
Acta Orthop Scand Suppl, 285, 62-8
DOI 10.1080/17453674.1999.11744826, PubMed 10429625

Saeter G, Wiebe T, Wiklund T, Monge O, Wahlqvist Y, Engstrom K, Forestier E, Holmstrom T, Stenwig AE, Willen H, Brosjo O, Folleras G, Alvegard TA, Strander H (1999)
Chemotherapy in osteosarcoma - The Scandinavian Sarcoma Group experience
Acta Orthop. Scand., 70 285, 74-82
DOI 10.1080/17453674.1999.11744828

Winderen M, Stenwig AE, Solheim OP, Saeter G, Aas M (1999)
Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients
Acta Orthop Scand Suppl, 285, 11-7
DOI 10.1080/17453674.1999.11744817, PubMed 10429616

Alvegard TA, Bauer H, Blomqvist C, Moller T, Rydholm A, Saeter G (1999)
The Scandinavian Sarcoma Group - Background, organization and the Central Register - the first 20 years
Acta Orthop. Scand., 70 285, 3-7
DOI 10.1080/17453674.1999.11744815

Elomaa I, Blomqvist C, Saeter G, Nilbert M, Monge OR, Wiebe T, Alvegård TA (1999)
Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience
Acta Orthop Scand Suppl, 285, 69-73
PubMed 10429626

Rydholm A, Gustafson P, Alvegard TA, Saeter G, Blomqvist C (1999)
Prognostic factors in soft tissue sarcoma - A review and the Scandinavian Sarcoma Group experience
Acta Orthop. Scand., 70 285, 50-57
DOI 10.1080/17453674.1999.11744824

Saeter G, Wiebe T, Wiklund T, Monge O, Wahlqvist Y, Engström K, Forestier E, Holmström T, Stenwig AE, Willén H, Brosjö O, Follerås G, Alvegård TA, Strander H (1999)
Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience
Acta Orthop Scand Suppl, 285, 74-82
PubMed 10429627

Elomaa I, Blomqvist C, Saeter G, Nilbert M, Monge OR, Wiebe T, Alvegard TA (1999)
Chemotherapy in Ewing's sarcoma - The Scandinavian Sarcoma Group experience
Acta Orthop. Scand., 70 285, 69-73
DOI 10.1080/17453674.1999.11744827

Micci F, Teixeira MR, Dietrich CU, Saeter G, Bjerkehagen B, Heim S (1999)
Combined RxFISH/G-banding allows refined karyotyping of solid tumors
Hum Genet, 104 (5), 370-5
DOI 10.1007/s004390050970, PubMed 10394927

Forus A, Berner JM, Meza-Zepeda LA, Saeter G, Mischke D, Fodstad O, Myklebost O (1998)
Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas
Br J Cancer, 78 (4), 495-503
DOI 10.1038/bjc.1998.521, PubMed 9716033

Nilbert M, Saeter G, Elomaa I, Monge OR, Wiebe T, Alvegård TA (1998)
Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV
Acta Oncol, 37 (4), 375-8
DOI 10.1080/028418698430601, PubMed 9743460

Saeter G, Alvegård TA, Monge OR, Strander H, Turesson I, Klepp R, Söderberg M, Wist E, Raabe N, Erlanson M, Solheim OP, Hannisdal E (1997)
Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study
Eur J Cancer, 33 (10), 1551-8
DOI 10.1016/s0959-8049(97)00102-0, PubMed 9389914

Wiklund T, Saeter G, Strander H, Alvegård T, Blomqvist C (1997)
The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group experience
Eur J Cancer, 33 (3), 357-61
DOI 10.1016/s0959-8049(97)89006-5, PubMed 9155517

Alvegård TA, Saeter G (1997)
The role of pulmonary metastasectomy for soft tissue sarcoma
Acta Orthop Scand Suppl, 273, 145-7
DOI 10.1080/17453674.1997.11744721, PubMed 9057606

Saeter G, Elomaa I, Wahlqvist Y, Alvegård TA, Wiebe T, Monge O, Forrestier E, Solheim OP (1997)
Prognostic factors in bone sarcomas
Acta Orthop Scand Suppl, 273, 156-60
DOI 10.1080/17453674.1997.11744723, PubMed 9057608

Saeter G, Alvegård TA, Elomaa I, Wiebe T, Björk O, Strander H, Solheim OP (1997)
Chemotherapy for osteosarcoma and Ewing's sarcoma
Acta Orthop Scand Suppl, 273, 120-5
DOI 10.1080/17453674.1997.11744716, PubMed 9057601

Saeter G (1997)
Chemotherapy for adult soft tissue sarcoma - Does it work?
Acta Orthop. Scand., 68 273, 139-144
DOI 10.1080/17453674.1997.11744720

Ekstrøm PO, Andersen A, Saeter G, Giercksky KE, Slørdal L (1997)
Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report
Cancer Chemother Pharmacol, 39 (3), 267-72
DOI 10.1007/s002800050571, PubMed 8996531

Lothe RA, Karhu R, Mandahl N, Mertens F, Saeter G, Heim S, Borresen-Dale AL, Kallioniemi OP (1996)
Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis
Cancer Res, 56 (20), 4778-81
PubMed 8840998

Saeter G, Bruland OS, Follerås G, Boysen M, Høie J (1996)
Extremity and non-extremity high-grade osteosarcoma -- the Norwegian Radium Hospital experience during the modern chemotherapy era
Acta Oncol, 35 Suppl 8, 129-34
DOI 10.3109/02841869609098531, PubMed 9073059

Saeter G, Høie J, Stenwig AE, Johansson AK, Hannisdal E, Solheim OP (1995)
Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival
Cancer, 75 (5), 1084-93
DOI 10.1002/1097-0142(19950301)75:5<1084::aid-cncr2820750506>3.0.co;2-f, PubMed 7850705

Lothe RA, Slettan A, Saeter G, Brøgger A, Børresen AL, Nesland JM (1995)
Alterations at chromosome 17 loci in peripheral nerve sheath tumors
J Neuropathol Exp Neurol, 54 (1), 65-73
DOI 10.1097/00005072-199501000-00008, PubMed 7815081

Skullerud K, Stenwig AE, Brandtzaeg P, Nesland JM, Kerty E, Langmoen I, Saeter G (1995)
Intracranial primary leiomyosarcoma arising in a teratoma of the pineal area
Clin Neuropathol, 14 (4), 245-8
PubMed 8521631

Saeter G, Talle K, Solheim OP (1995)
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide
Cancer Chemother Pharmacol, 36 (2), 172-5
DOI 10.1007/BF00689204, PubMed 7539339

Solheim OP, Saeter G, Høie J, Talle K, Stenwig AE, Winderen M, Walaas L, Follerås G (1994)
[Treatment of chondrosarcoma. A retrospective study at the Norwegian Radium Hospital]
Tidsskr Nor Laegeforen, 114 (26), 3075-8
PubMed 7974427

Seglen P, Saeter G, Schwarze P (1994)
Proliferation of diploid hepatocytes and nonparenchymal (oval) cells during rat-liver regeneration in the presence of 2-acetylaminofluorene
Int J Oncol, 5 (4), 805-10
DOI 10.3892/ijo.5.4.805, PubMed 21559645

Saetersdal AB, Saeter G, Solheim OP, Talle K, Stenwig AE, Winderen M, Follerås G (1993)
[Diagnostic aspects of subacute osteomyelitis in children and adolescents. Clinical and radiographic resemblance to primary malignant tumors]
Tidsskr Nor Laegeforen, 113 (26), 3240-3
PubMed 8236217

Lothe RA, Saeter G, Danielsen HE, Stenwig AE, Høyheim B, O'Connell P, Børresen AL (1993)
Genetic alterations in a malignant schwannoma from a patient with neurofibromatosis (NF1)
Pathol Res Pract, 189 (4), 465-71; discussion 471-4
DOI 10.1016/S0344-0338(11)80339-0, PubMed 8351250

Solheim OP, Saeter G, Finnanger AM, Stenwig AE (1992)
High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study
Br J Cancer, 65 (6), 956-60
DOI 10.1038/bjc.1992.200, PubMed 1616870

Solheim OP, Saeter G, Elomaa I, Alvegård TA (1992)
The treatment of osteosarcoma: present trends. The Scandinavian Sarcoma Group experience
Ann Oncol, 3 Suppl 2, S7-11
DOI 10.1093/annonc/3.suppl_2.s7, PubMed 1622872

Saeter G, Alvegård TA, Elomaa I, Stenwig AE, Holmström T, Solheim OP (1991)
Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study
J Clin Oncol, 9 (10), 1766-75
DOI 10.1200/JCO.1991.9.10.1766, PubMed 1717666

Lien HH, Blomlie V, Saeter G, Solheim O, Fosså SD (1991)
Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate
Radiology, 179 (2), 547-50
DOI 10.1148/radiology.179.2.2014309, PubMed 2014309

Schwarze PE, Saeter G, Armstrong D, Cameron RG, Laconi E, Sarma DS, Préat V, Seglen PO (1991)
Diploid growth pattern of hepatocellular tumours induced by various carcinogenic treatments
Carcinogenesis, 12 (2), 325-7
DOI 10.1093/carcin/12.2.325, PubMed 1847321

Seglen PO, Saeter G, Schwarze PE (1990)
Liver tumor promoters stimulate growth of transplanted hepatocellular carcinomas
Hepatology, 12 (2), 295-300
DOI 10.1002/hep.1840120217, PubMed 2167869

Fosså SD, Saeter G, Aass N, Ous S, Stenwig AE, Blomlie V (1990)
Management of patients with poor-prognosis nonseminomatous germ cell cancer
Oncology, 47 (3), 234-40
DOI 10.1159/000226822, PubMed 1692984

Saeter G, Schwarze PE, Nesland JM, Seglen PO (1989)
Diploid nature of hepatocellular tumours developing from transplanted preneoplastic liver cells
Br J Cancer, 59 (2), 198-205
DOI 10.1038/bjc.1989.41, PubMed 2930686

Seglen PO, Skomedal H, Saeter G, Schwarze PE, Nesland JM (1989)
Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours
Carcinogenesis, 10 (1), 21-5
DOI 10.1093/carcin/10.1.21, PubMed 2910524

Saeter G, Lee CZ, Schwarze PE, Ous S, Chen DS, Sung JL, Seglen PO (1988)
Changes in ploidy distributions in human liver carcinogenesis
J Natl Cancer Inst, 80 (18), 1480-5
DOI 10.1093/jnci/80.18.1480, PubMed 2846856

Saeter G, Schwarze E, Seglen O (1988)
Shift from polyploidizing to nonpolyploidizing growth in carcinogen-treated rat liver
J Natl Cancer Inst, 80 (12), 950-8
DOI 10.1093/jnci/80.12.950, PubMed 3398071

Saeter G, Schwarze PE, Nesland JM, Juul N, Pettersen EO, Seglen PO (1988)
The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas
Carcinogenesis, 9 (6), 939-45
DOI 10.1093/carcin/9.6.939, PubMed 3370757

Saeter G, Schwarze PE, Nesland JM, Seglen PO (1988)
2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism
Carcinogenesis, 9 (4), 581-7
DOI 10.1093/carcin/9.4.581, PubMed 2895691

Holte H, Saeter G, Dahl IM, Abrahamsen AF (1987)
Progressive loss of vision in patients with high-grade non-Hodgkin's lymphoma
Cancer, 60 (10), 2521-3
DOI 10.1002/1097-0142(19871115)60:10<2521::aid-cncr2820601029>3.0.co;2-n, PubMed 3664433

Saeter G, Fosså SD, Norman N (1987)
Gynaecomastia following cytotoxic therapy for testicular cancer
Br J Urol, 59 (4), 348-52
DOI 10.1111/j.1464-410x.1987.tb04647.x, PubMed 3107651

Saeter G, Schwarze PE, Nesland JM, Seglen PO (1987)
Transplantation of preneoplastic rat hepatocytes by intraportal injection
Toxicol Pathol, 15 (1), 78-81
DOI 10.1177/019262338701500110, PubMed 3554470

Brincker H, Saeter G (1986)
Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy
Cancer, 57 (6), 1124-9
DOI 10.1002/1097-0142(19860315)57:6<1124::aid-cncr2820570611>3.0.co;2-d, PubMed 3943036

Saeter G, Ottestad L, Karlsen KO (1986)
[Implanted subcutaneous injection port. When is continuous venous access needed]
Tidsskr Nor Laegeforen, 106 (7), 577-9
PubMed 3961785

Seglen PO, Schwarze PE, Saeter G (1986)
Changes in cellular ploidy and autophagic responsiveness during rat liver carcinogenesis
Toxicol Pathol, 14 (3), 342-8
DOI 10.1177/019262338601400309, PubMed 3787117

Saeter G (1985)
[Calcitonin as an analgesic agent in the treatment of skeletal metastases]
Tidsskr Nor Laegeforen, 105 (26), 1782-4
PubMed 2414858

Saeter G, Fosså SD, Ous S, Blom GP, Kaalhus O (1984)
Carcinoma of the prostate with soft tissue or non-regional lymphatic metastases at the time of diagnosis: a review of 47 cases
Br J Urol, 56 (4), 385-90
DOI 10.1111/j.1464-410x.1984.tb05827.x, PubMed 6534426

Saeter G, Gundersen S, Høst H (1983)
[Extravasal injection of cytostatics. Special reference to adriamiycin]
Tidsskr Nor Laegeforen, 103 (33), 2260-2
PubMed 6658755

Review articles

Wind A, Oberst S, Westerhuis W, Blaauwgeers H, Sæter G, de Paoli P, Nagy P, Burrion JB, Jolly E, Lovey J, van Harten W (2023)
Evaluating comprehensive cancer networks; a review of standards and evaluation methods for care networks to inform a comparison with the OECI comprehensive cancer network standards
Acta Oncol, 62 (1), 15-24
DOI 10.1080/0284186X.2023.2170275, PubMed 36786345

Lehne G, Bjørheim J, Saeter G (2007)
[Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?]
Tidsskr Nor Laegeforen, 127 (8), 1040-4
PubMed 17457389

Bauer HC, Alvegård TA, Berlin O, Erlanson M, Gustafson P, Kivioja A, Klepp R, Lehtinen T, Lindholm P, Möller TR, Rydholm A, Saeter G, Trovik CS, Wahlström O, Wiklund T (1999)
The Scandinavian Sarcoma Group Register
Acta Orthop Scand Suppl, 285, 41-4
DOI 10.1080/17453674.1999.11744821, PubMed 10429620

Rydholm A, Gustafson P, Alvegård TA, Saeter G, Blomqvist C (1999)
Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience
Acta Orthop Scand Suppl, 285, 50-7
PubMed 10429623

Saeter G (1997)
Chemotherapy for adult soft tissue sarcoma. Does it work?
Acta Orthop Scand Suppl, 273, 139-44
PubMed 9057605

Saeter G, Seglen PO (1990)
Cell biology of hepatocarcinogenesis
Crit Rev Oncog, 1 (4), 437-66
PubMed 1964598